scholarly article | Q13442814 |
P2093 | author name string | Robert Meller | |
P2860 | cites work | Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein | Q22009972 |
Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination | Q23919600 | ||
Monoubiquitylation promotes mitochondrial p53 translocation | Q24295012 | ||
A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate | Q24297635 | ||
SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia | Q24299542 | ||
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling | Q24299573 | ||
Two different classes of E2 ubiquitin-conjugating enzymes are required for the mono-ubiquitination of proteins and elongation by polyubiquitin chains with a specific topology | Q24301551 | ||
CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity | Q24302505 | ||
ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways | Q24321528 | ||
RACK1 and CIS mediate the degradation of BimEL in cancer cells | Q24322936 | ||
MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin | Q24323363 | ||
Nucleotide sequence analysis of a cDNA encoding human ubiquitin reveals that ubiquitin is synthesized as a precursor | Q24328877 | ||
Nerve growth factor induced neurite outgrowth from amphibian neuroepithelial precursor cells is prevented by dipeptides inhibiting ubiquitin-mediated proteolysis | Q71612479 | ||
Rapid alterations in dendrite morphology during sublethal hypoxia or glutamate receptor activation | Q71937376 | ||
Calpain activation contributes to dendritic remodeling after brief excitotoxic injury in vitro | Q71970986 | ||
Spreading Depression Induces Tolerance of Cortical Neurons to Ischemia in Rat Brain | Q72055404 | ||
Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia | Q73089277 | ||
Ischemic tolerance in the brain | Q73089879 | ||
CREB phosphorylation promotes nerve cell survival | Q73120719 | ||
Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity | Q73338074 | ||
Bcl-w expression is increased in brain regions affected by focal cerebral ischemia in the rat | Q73477438 | ||
Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27 | Q73693632 | ||
Neurite outgrowth in PC12 cells. Distinguishing the roles of ubiquitylation and ubiquitin-dependent proteolysis | Q77336007 | ||
Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance | Q81497409 | ||
Regulatory phosphorylation of Bim: sorting out the ERK from the JNK | Q81833475 | ||
Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency | Q37039050 | ||
Molecular physiology of preconditioning-induced brain tolerance to ischemia | Q37056974 | ||
Autophagic neuron death in neonatal brain ischemia/hypoxia | Q37062794 | ||
Apoptosis meets autophagy-like cell death in the ischemic penumbra: Two sides of the same coin? | Q37102090 | ||
Mechanisms of lysosomal proteases participating in cerebral ischemia-induced neuronal death | Q37120227 | ||
Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy | Q37221596 | ||
CREB-mediated Bcl-2 protein expression after ischemic preconditioning. | Q38332115 | ||
Ubiquitin proteasome-mediated synaptic reorganization: a novel mechanism underlying rapid ischemic tolerance | Q39274473 | ||
Extreme anoxia tolerance in embryos of the annual killifish Austrofundulus limnaeus: insights from a metabolomics analysis | Q39361329 | ||
Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. | Q39451489 | ||
Ubiquitin: Roles in protein modification and breakdown | Q40136591 | ||
Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. | Q40323778 | ||
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. | Q40662652 | ||
Proteinase yscE, the yeast proteasome/multicatalytic-multifunctional proteinase: mutants unravel its function in stress induced proteolysis and uncover its necessity for cell survival | Q41080038 | ||
Limb remote-preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning | Q41481378 | ||
Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? | Q41604222 | ||
Lysosomal localization of ubiquitinated Jun requires multiple determinants in a lysine-27-linked polyubiquitin conjugate | Q42044297 | ||
Anoxia tolerance of con-familial tiger beetle larvae is associated with differences in energy flow and anaerobiosis | Q42047744 | ||
Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction | Q42487657 | ||
Differences between rat primary cortical neurons and astrocytes in purine release evoked by ischemic conditions | Q42526953 | ||
Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling | Q42614287 | ||
Structural properties of polyubiquitin chains in solution | Q42689368 | ||
c-Cbl is not required for ERK1/2-dependent degradation of BimEL. | Q43098314 | ||
Dendritic spines lost during glutamate receptor activation reemerge at original sites of synaptic contact. | Q43551117 | ||
NMDA receptors mediate hypoxic spine loss in cultured neurons | Q43720234 | ||
Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist | Q43874157 | ||
Signal-induced site specific phosphorylation targets Bcl2 to the proteasome pathway. | Q44094731 | ||
Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration | Q44261071 | ||
Effects of lipopolysaccharide priming on acute ischemic brain injury | Q44685571 | ||
Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519. | Q44827197 | ||
Cathepsin B-like proteolysis and MARCKS degradation in sub-lethal NMDA-induced collapse of dendritic spines | Q45086246 | ||
A proteasome-sensitive connection between PSD-95 and GluR1 endocytosis | Q45086259 | ||
Sumoylation increases HIF-1alpha stability and its transcriptional activity | Q45090303 | ||
Sequential E2s drive polyubiquitin chain assembly on APC targets | Q46225392 | ||
Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury | Q46400463 | ||
Geldanamycin treatment reduces delayed CA1 damage in mouse hippocampal organotypic cultures subjected to oxygen glucose deprivation | Q46464959 | ||
Recovery from ischemic brain injury in the rat following a 10 h delayed injection with MLN519. | Q46490706 | ||
Diverse polyubiquitin interaction properties of ubiquitin-associated domains | Q46592679 | ||
Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists | Q46910242 | ||
Excitotoxic loss of post-synaptic sites is distinct temporally and mechanistically from neuronal death | Q46943480 | ||
The proteasome inhibitor VELCADE reduces infarction in rat models of focal cerebral ischemia | Q46953900 | ||
Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity. | Q46979959 | ||
Phenotypes of Drosophila brain neurons in primary culture reveal a role for fascin in neurite shape and trajectory. | Q47072586 | ||
Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study | Q47205226 | ||
Opening of ATP-sensitive potassium channels by cromakalim confers tolerance against chemical ischemia in rat neuronal cultures | Q47712610 | ||
Prevention from hypoxia-induced apoptosis by pre-conditioning: a mechanistic approach in cultured neurons from fetal rat forebrain | Q47759766 | ||
Hypoxia stabilizes type 2 deiodinase activity in rat astrocytes | Q48113477 | ||
Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice | Q48158714 | ||
Local cerebral blood flow during hibernation, a model of natural tolerance to "cerebral ischemia". | Q48164910 | ||
Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states | Q48182556 | ||
Evidence from cultured rat cortical neurons of differences in the mechanism of ischemic preconditioning of brain and heart | Q48215599 | ||
Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance | Q48258831 | ||
Rapid preconditioning neuroprotection following anoxia in hippocampal slices: role of the K+ ATP channel and protein kinase C. | Q48264329 | ||
Adaptation of adult brain tissue to anoxia and hypoxia in vitro | Q48342251 | ||
A balance of protein synthesis and proteasome-dependent degradation determines the maintenance of LTP. | Q48394969 | ||
Ubiquitin immunoreactivity of multiple polypeptides in rat brain synaptic membranes | Q48490108 | ||
Hibernation in Ground Squirrels Induces State and Species-Specific Tolerance to Hypoxia and Aglycemia: An In Vitro Study in Hippocampal Slices | Q48532413 | ||
Activity-dependent ubiquitination of GABA(A) receptors regulates their accumulation at synaptic sites | Q48542489 | ||
Anoxic preconditioning in hippocampal slices: role of adenosine | Q48853526 | ||
Preconditioning of primary rat neuronal cultures against ischemic injury: characterization of the "time window of protection'. | Q48858502 | ||
Rapid reversible changes in dendritic spine structure in vivo gated by the degree of ischemia. | Q48874149 | ||
'Ischemic tolerance' phenomenon found in the brain | Q48895274 | ||
ALTERATIONS IN LYSOSOMES (INTRACELLULAR ENZYMES) DURING SHOCK; EFFECTS OF PRECONDITIONING (TOLERANCE) AND PROTECTIVE DRUGS | Q50268727 | ||
Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. | Q52537613 | ||
Genomics of preconditioning | Q53633445 | ||
E3-independent monoubiquitination of ubiquitin-binding proteins. | Q55044113 | ||
Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85 | Q70212185 | ||
Recognition of the polyubiquitin proteolytic signal | Q24530006 | ||
Bim: a novel member of the Bcl-2 family that promotes apoptosis | Q24532974 | ||
Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series | Q24655287 | ||
Mechanisms underlying ubiquitination | Q27860656 | ||
Ubc9p Is the Conjugating Enzyme for the Ubiquitin-like Protein Smt3p | Q27930030 | ||
Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities. | Q27933653 | ||
A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. | Q27935265 | ||
Pathobiology of ischaemic stroke: an integrated view | Q28141682 | ||
Molecular cloning and characterization of six novel isoforms of human Bim, a member of the proapoptotic Bcl‐2 family1 | Q28208950 | ||
Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis | Q28212224 | ||
CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation | Q28216253 | ||
Back to the future with ubiquitin | Q28240711 | ||
Modification of proteins by ubiquitin and ubiquitin-like proteins | Q28244250 | ||
The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular components | Q28253543 | ||
Concepts in sumoylation: a decade on | Q28257220 | ||
The ubiquitin-proteasome system in Alzheimer's disease | Q28268311 | ||
Proteasome-independent functions of ubiquitin in endocytosis and signaling | Q28282959 | ||
Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor | Q28300145 | ||
Activity-dependent dynamics and sequestration of proteasomes in dendritic spines | Q28507040 | ||
Androgen-dependent apoptosis in male germ cells is regulated through the proto-oncoprotein Cbl | Q28564996 | ||
Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression | Q28566984 | ||
Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model | Q28575710 | ||
Protein kinase C-gamma and calcium/calmodulin-dependent protein kinase II-alpha are persistently translocated to cell membranes of the rat brain during and after middle cerebral artery occlusion | Q28576827 | ||
Role of ubiquitin carboxy terminal hydrolase-L1 in neural cell apoptosis induced by ischemic retinal injury in vivo | Q28585083 | ||
Proteolysis of AKAP121 regulates mitochondrial activity during cellular hypoxia and brain ischaemia | Q28590290 | ||
Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85 | Q28591666 | ||
Proteasomes and their kin: proteases in the machine age | Q29614359 | ||
The Proteasome: Paradigm of a Self-Compartmentalizing Protease | Q29615187 | ||
BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly | Q29617135 | ||
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system | Q29617400 | ||
Histone ubiquitination: triggering gene activity | Q29617523 | ||
Protein regulation by monoubiquitin | Q29620221 | ||
Protection by rapid chemical preconditioning of stressed hippocampal slice: a study of cellular swelling using optical scatter imaging. | Q30836232 | ||
Rapid cerebral ischemic preconditioning in mice deficient in endothelial and neuronal nitric oxide synthases. | Q31137380 | ||
Ischemic Preconditioning and Brain Tolerance: Temporal Histological and Functional Outcomes, Protein Synthesis Requirement, and Interleukin-1 Receptor Antagonist and Early Gene Expression | Q32024563 | ||
Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration | Q33187817 | ||
Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator | Q33236872 | ||
Anoxia tolerance in turtles: metabolic regulation and gene expression | Q33260127 | ||
The role of the ubiquitin-proteasome pathway in apoptosis | Q33669467 | ||
Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy | Q33998182 | ||
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. | Q34107309 | ||
Proteasomes in apoptosis: villains or guardians? | Q34158571 | ||
Polyubiquitination of p53 by a ubiquitin ligase activity of p300. | Q34190044 | ||
The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control | Q34194899 | ||
Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons | Q34446404 | ||
Caspase 3 activation is essential for neuroprotection in preconditioning | Q34470616 | ||
Cerebral ischemic preconditioning. An experimental phenomenon or a clinical important entity of stroke prevention? | Q34990903 | ||
Animal models of focal and global cerebral ischemia | Q35090269 | ||
Ischemic tolerance and endogenous neuroprotection | Q35126696 | ||
Mammalian hibernation. Transcriptional and translational controls. | Q35624297 | ||
Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression | Q35663874 | ||
Ischemic preconditioning: nearly two decades of research. A comprehensive review | Q35690601 | ||
Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. | Q35760480 | ||
Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all. | Q36092032 | ||
Co-translational protein aggregation after transient cerebral ischemia | Q36180631 | ||
Lingering mysteries of ubiquitin-chain assembly | Q36368593 | ||
The ARF tumour suppressor | Q36442822 | ||
The complexity of p53 stabilization and activation | Q36443523 | ||
Ischemic preconditioning prevents protein aggregation after transient cerebral ischemia | Q36455545 | ||
Protein ubiquitination in postsynaptic densities after transient cerebral ischemia | Q36455548 | ||
Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury | Q36559658 | ||
Proteasome inhibition enhances the induction and impairs the maintenance of late-phase long-term potentiation | Q36625561 | ||
Ischaemic preconditioning of the brain, mechanisms and applications | Q36676111 | ||
Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells | Q36676352 | ||
Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis | Q36721626 | ||
Emerging roles for ubiquitin and protein degradation in neuronal function | Q36747899 | ||
Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies | Q37027500 | ||
The age of crosstalk: phosphorylation, ubiquitination, and beyond | Q37033138 | ||
P433 | issue | 3 | |
P921 | main subject | ubiquitin-proteasome system | Q47175589 |
P304 | page(s) | 243-260 | |
P577 | publication date | 2009-01-30 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | The Neuroscientist | Q7753449 |
P1476 | title | The role of the ubiquitin proteasome system in ischemia and ischemic tolerance | |
P478 | volume | 15 |
Q34392217 | A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions. |
Q36752376 | A critical review of mechanisms regulating remote preconditioning-induced brain protection |
Q92381302 | Changes in cerebral autoregulation and blood biomarkers after remote ischemic preconditioning |
Q34848063 | Comprehensive gene expression profiling reveals synergistic functional networks in cerebral vessels after hypertension or hypercholesterolemia. |
Q26853743 | Glucocorticoids and endothelial cell barrier function |
Q38078689 | Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke. |
Q37848658 | In vivo contributions of BH3-only proteins to neuronal death following seizures, ischemia, and traumatic brain injury |
Q49012326 | Ischaemia-Induced Protein Ubiquitinylation is Differentially Accompanied with Heat-Shock Protein 70 Expression After Naïve and Preconditioned Ischaemia |
Q35085241 | Ischemic tolerance in an in vivo model of glutamate preconditioning |
Q41598067 | Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. |
Q53202813 | Overexpression of the human ubiquitin E3 ligase CUL4A alleviates hypoxia–reoxygenation injury in pheochromocytoma (PC12) cells |
Q38045663 | Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis |
Q30356816 | Patterns of ubiquitylation and SUMOylation associated with exposure to anoxia in embryos of the annual killifish Austrofundulus limnaeus |
Q39181325 | Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases |
Q53213546 | Role of p97/Valosin-containing protein (VCP) and Jab1/CSN5 in testicular ischaemia-reperfusion injury. |
Q37989861 | Role of the ubiquitin-proteasome system in nervous system function and disease: using C. elegans as a dissecting tool |
Q36349945 | The point mutation UCH-L1 C152A protects primary neurons against cyclopentenone prostaglandin-induced cytotoxicity: implications for post-ischemic neuronal injury |
Q27023731 | Therapeutic Angiogenesis: Controlled Delivery of Angiogenic Factors |
Q34854026 | Towards a dynamical network view of brain ischemia and reperfusion. Part I: background and preliminaries |
Q83328402 | Ubiquinol‐induced gene expression signatures are translated into altered parameters of erythropoiesis and reduced low density lipoprotein cholesterol levels in humans |
Q38954134 | Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection |
Q47721585 | Variations in target gene expression and pathway profiles in the mouse hippocampus following treatment with different effective compounds for ischemia–reperfusion injury |
Q86954611 | [Sarcopenia and frailty in neurology] |
Q33783826 | mTORC2 phosphorylation of Akt1: a possible mechanism for hydrogen sulfide-induced cardioprotection |
Search more.